Every week we scour the news for the latest headlines in Alzheimer’s stories, care, treatment, and prevention. Here is this week’s biggest story for the week of July 23rd, 2012 – July 29th 2012.
Alzheimer’s Drug Fails Its First Big Clinical Trial
The most closely watched experimental treatment for Alzheimer’s disease proved ineffective in its first large clinical trial, dealing a blow to the field, to a theory about the cause of the disease, and to the three companies behind the drug. Pfizer announced that the drug, bapineuzumab, did not improve either cognition or daily functioning of patients compared to a placebo in the Phase 3 trial.
